The 10-year deal will help support Washington University’s personalized medicine initiative, which aims to find and develop customized disease treatments and prevention for patients.
Any innovation that is discovered from the research will be commercialized through a joint venture between the school and Centene.
“We believe personalized medicine is the path to ensure patients get the targeted healthcare they need to fight disease, and we look forward to partnering with such a renowned medical school to initially focus on four diseases that impact millions of Americans, including many of our health plan members,” said Michael Neidorff, chairman and CEO of Centene.
More articles on payers:
BCBS of Texas to open primary care clinics: 5 things to know
128,000 kids lost health insurance in Tennessee over 2 years — Here’s why
Pennsylvania woman denied coverage for sepsis-related foot amputation
